Overview
Infantile-onset generalized dyskinesia with orofacial involvement is a rare neurological condition that begins in the first year or two of life. 'Dyskinesia' means uncontrolled, involuntary movements — movements the child cannot stop or start on purpose. In this condition, those movements affect the whole body (generalized) and are especially noticeable in the face and mouth area (orofacial), causing grimacing, tongue movements, and unusual facial expressions. The arms, legs, and trunk are also involved, making it hard for the child to sit still, reach for objects, or move in a coordinated way. The condition is caused by changes (variants) in specific genes that affect how the brain controls movement. It is sometimes referred to by its Orphanet code ORPHA:494526. The exact gene or genes involved may vary between families. Because the movements are present from infancy, they can interfere with feeding, speech development, and learning to walk. Treatment today focuses on managing symptoms rather than curing the disease. Medications used for movement disorders — such as those that calm overactive movement signals in the brain — may help reduce the severity of the involuntary movements. Physical therapy, occupational therapy, and speech therapy play an important role in helping children reach their best possible development. Research into this condition is still in early stages, and care is typically managed by a team of specialists.
Also known as:
Key symptoms:
Uncontrolled, involuntary movements of the whole bodyUnusual facial movements such as grimacing or tongue writhingDifficulty controlling arm and leg movementsTrouble with feeding and swallowing in infancyDelayed or unclear speech developmentDifficulty sitting still or maintaining postureChallenges with fine motor skills like grasping objectsPossible delays in reaching movement milestones like walkingMuscle tone that may be too low or too high at different timesPossible irritability or distress related to uncontrolled movements
Clinical phenotype terms (13)— hover any for plain English
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Infantile-onset generalized dyskinesia with orofacial involvement.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Infantile-onset generalized dyskinesia with orofacial involvement at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Infantile-onset generalized dyskinesia with orofacial involvement.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Infantile-onset generalized dyskinesia with orofacial involvement.
Community
No community posts yet. Be the first to share your experience with Infantile-onset generalized dyskinesia with orofacial involvement.
Start the conversation →Latest news about Infantile-onset generalized dyskinesia with orofacial involvement
No recent news articles for Infantile-onset generalized dyskinesia with orofacial involvement.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What genetic tests should my child have, and how long will results take?,Which medications are most likely to help reduce my child's movements, and what side effects should I watch for?,Should my child be evaluated for deep brain stimulation, and if so, when?,What therapies are most important right now, and how often should my child receive them?,Are there any clinical trials or research studies my child might be eligible for?,How will this condition affect my child's learning and development, and what school supports should we request?,Is there a patient registry or specialist center that focuses on this type of movement disorder where we could get a second opinion?
Common questions about Infantile-onset generalized dyskinesia with orofacial involvement
What is Infantile-onset generalized dyskinesia with orofacial involvement?
Infantile-onset generalized dyskinesia with orofacial involvement is a rare neurological condition that begins in the first year or two of life. 'Dyskinesia' means uncontrolled, involuntary movements — movements the child cannot stop or start on purpose. In this condition, those movements affect the whole body (generalized) and are especially noticeable in the face and mouth area (orofacial), causing grimacing, tongue movements, and unusual facial expressions. The arms, legs, and trunk are also involved, making it hard for the child to sit still, reach for objects, or move in a coordinated way
At what age does Infantile-onset generalized dyskinesia with orofacial involvement typically begin?
Typical onset of Infantile-onset generalized dyskinesia with orofacial involvement is infantile. Age of onset can vary across affected individuals.